Executive Director, Scientific Communication and External Research @ (March 2021 - Present)
Senior Director, Scientific Affairs @ (August 2017 - March 2021)
National Director, Medical Science Liaisons @ (July 2015 - July 2017)
Director, Medical Affairs Operations @ (April 2014 - June 2015)
Principal Medical Science Liaison @ (January 2014 - April 2014)
Lead Scientific Communication, Janssen Therapeutics EMEA @ (October 2012 - January 2014)
Principal Science and Research Liaison @ (August 2008 - October 2012)
Science and Research Liaison @ (March 2006 - August 2008)
Infectious Diseases Clinical Pharmacist @ Edward Hines Jr Va Hospital (July 2000 - March 2006)
Infectious Diseases Fellow @ (July 1998 - June 2000)
Pharmacy Practice Resident @ Richland Memorial Hospital Columbia South Carolina (May 1997 - June 1998)
Joan Cannon Education
Drexel
Master of Business Administration
2011-2013
University of Illinois at Chicago
Doctor of Pharmacy
1993-1997
Illinois
(Pharmacy)
1991-1993
Joan Cannon Skills
Pharmaceutical Industry
Infectious Diseases
Medical Affairs
Clinical Trials
Clinical Research
Drug Development
Oncology
Managed Care
Clinical Development
Pharmacists
Pharmacology
Pharmacy
Medical Writing
Therapeutic Areas
Clinical Pharmacology
Pharmacovigilance
Gastroenterology
Healthcare
Strategic Planning
Sales Management
Medicine
New Business Development
Microsoft Excel
Management
Training
Account Management
Public Speaking
Research
Project Management
Teaching
Joan Cannon Summary
Joan Cannon, based in Chicago, IL, US, is currently a Vice President, Scientific Communications at TerSera Therapeutics LLC. Joan Cannon brings experience from previous roles at Tersera Therapeutics and Lundbeck. Joan Cannon holds a 2011 - 2013 Master of Business Administration @ Drexel. With a robust skill set that includes Pharmaceutical Industry, Infectious Diseases, Medical Affairs, Clinical Trials, Clinical Research and more. Joan Cannon has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Joan Cannon?
Find contact details for 700 million professionals.